Intech Biopharm Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 38.9 million compared to TWD 21.11 million a year ago. Net loss was TWD 301.76 million compared to TWD 250.37 million a year ago. Basic loss per share from continuing operations was TWD 2.97 compared to TWD 2.5 a year ago. Diluted loss per share from continuing operations was TWD 2.97 compared to TWD 2.5 a year ago.